The patient with a SMARCB1-deficient testicular tumor reported in the present study experienced disease progression and multiple metastases only 4 months after the surgery, which shows that tumors with SMARCB1 deficiency are highly malignant and invasive. The gene discussed is SMARCB1; the disease is neoplasm of testis.